Beijing-based biomaterial firm Bluepha has snapped 400 million yuan ($58.3 million) in an extended Series B round led by Zhong Ping Capital.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in